About Pyxus Pharmaceuticals Private Limited
Data last updated:
Pyxus Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2018PTC103565. Its GSTIN is 24AAKCP0094Q1ZW (Gujarat).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Abbasali Mahammadali Balospura and Ahemadabbas Gulamhaidar Balospura.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at A/707 Mondeal Heights Beside Novotel Hotel Nr. Iscon Square S.G. Highway, Ahmedabad, Gujarat, India – 380015.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.91 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹62.1 Lakh (net margin 2.5%) and EBITDA of ₹1.22 Cr (EBITDA margin 4.9%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 11% over five years.
As per MCA filings, the company has open charges of ₹29.98 Cr on record. Court records list 1 case involving the company.
For more details, the company can be reached via its website pyxuspharmaceuticals.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressA/707 Mondeal Heights Beside Novotel Hotel Nr. Iscon Square S.G. Highway, Ahmedabad, Gujarat, India – 380015
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Pyxus Pharmaceuticals Private Limited
The main business activity of Pyxus Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Pyxus Pharmaceuticals Private Limited FY 2024 filings available
Pyxus Pharmaceuticals Private Limited reported revenue of ₹24.91 Cr (down 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Pyxus Pharmaceuticals Private Limited
Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 11%. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pyxus Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.22 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹62.1 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pyxus Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pyxus Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Pyxus Pharmaceuticals Private Limited
Pyxus Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anthus Pharmaceuticals Private Limited | ₹24.97 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Chennai, Tamil Nadu, India |
| Biovitamins Private Limited | ₹24.97 Cr (FY 2025) | •••• | •••• | 35.0% | •••• | Bangalore South, Karnataka, India |
| Chemosyn Limited | ₹24.95 Cr (FY 2025) | •••• | •••• | -22.0% | •••• | Mumbai, Maharashtra, India |
| Thrift Pharmaceuticals Private Limited | ₹24.95 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Baroda, Gujarat, India |
| Eucare Pharmaceuticals P Ltd | ₹24.93 Cr (FY 2024) | •••• | •••• | 31.0% | •••• | 44., Tamil Nadu, India |
| Pyxus Pharmaceuticals Private Limited this company | ₹24.91 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Ahmedabad, Gujarat, India |
| Artura Pharmaceuticals Private Limited | ₹24.89 Cr (FY 2024) | •••• | •••• | 37.0% | •••• | Chennai, Tamil Nadu, India |
| Greentech Laboratories Private Limited | ₹24.88 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Srikakulam, Andhra Pradesh, India |
| Sumit Pharmaceuticals Private Limited | ₹24.86 Cr (FY 2025) | •••• | •••• | 34.0% | •••• | Lucknow, Uttar Pradesh, India |
| Us Amino Private Limited | ₹24.84 Cr (FY 2024) | •••• | •••• | -3.0% | •••• | Mavli, Rajasthan, India |
| Drdelight Pharmaceuticals Private Limited | ₹24.84 Cr (FY 2024) | •••• | •••• | 21192.0% | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Pyxus Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Pyxus Pharmaceuticals Private Limited
Pyxus Pharmaceuticals Private Limited is audited by R A Y S & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R A Y S & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Pyxus Pharmaceuticals Private Limited
Pyxus Pharmaceuticals has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abbasali Mahammadali Balospura | Director | 01 Jan 2021 | 5 Years 9 Months | Current |
| Ahemadabbas Gulamhaidar Balospura | Director | 08 Aug 2018 | 8 Years 2 Months | Current |
| Salam Waheed Ahjel | Director | 08 Aug 2018 | 8 Years 2 Months | Current |
| Aabid Ali Also directs: Joinhub Pharma LLP, Aliyan Pharmaceuticals LLP, Emed Healthtech Private Limited and 2 more | Additional Director | 02 Dec 2025 | 0 Years 10 Months | Current |
Ownership and Shareholding of Pyxus Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pyxus Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Sep 2023 | Others | ₹29.98 Cr | Open |
Total charge records: 1 View all charges
Legal Cases of Pyxus Pharmaceuticals Private Limited
Pyxus Pharmaceuticals Private Limited has 1 court case on record: 1 where it is another party. All case is disposed. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Company is another party | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Pyxus Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Pyxus Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pyxus Pharmaceuticals Private Limited
Pyxus Pharmaceuticals Private Limited has 9 board changes on record since 2018: 5 appointments and 4 cessations. The latest: Aabid Ali was appointed as Additional Director on 02 Dec 2025.
2 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Pyxus Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pyxus Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pyxus Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pyxus Pharmaceuticals Private Limited
Pyxus Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAKCP0094Q1ZW | Gujarat | Active | 02 Oct 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pyxus Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pyxus Pharmaceuticals Private Limited
Pyxus Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 August 2018 (8+ years old) and is registered under CIN U74999GJ2018PTC103565.
Pyxus Pharmaceuticals reported revenue of ₹24.91 Cr for FY 2025 (down 4% YoY).
Pyxus Pharmaceuticals has 4 current directors:
- Abbasali Mahammadali Balospura - Director
- Ahemadabbas Gulamhaidar Balospura - Director
- Salam Waheed Ahjel - Director
- Aabid Ali - Additional Director
Pyxus Pharmaceuticals reported a net profit of ₹62.1 Lakh (net margin 2.5%) and EBITDA of ₹1.22 Cr (EBITDA margin 4.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pyxus Pharmaceuticals is 14% over three years and 11% over five years. In the latest year (FY 2025) revenue fell 4%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Pyxus Pharmaceuticals is 24AAKCP0094Q1ZW, registered in Gujarat.
The CIN (Corporate Identification Number) of Pyxus Pharmaceuticals is U74999GJ2018PTC103565. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pyxus Pharmaceuticals has 1 court case on record.
Pyxus Pharmaceuticals was incorporated on 08 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Pyxus Pharmaceuticals by revenue are Anthus Pharmaceuticals Private Limited, Biovitamins Private Limited, Chemosyn Limited, Thrift Pharmaceuticals Private Limited, Eucare Pharmaceuticals P Ltd and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Aabid Ali was appointed as Additional Director on 02 Dec 2025. Basheer Ali Awad Alazzawi ceased to be Director on 11 Mar 2024. Sanket Vinodbhai Shah ceased to be Additional Director on 30 Sep 2022. Pyxus Pharmaceuticals has 9 board changes on record in total.